Fortrea Holdings (FTRE) Goodwill (2022 - 2026)
Fortrea Holdings' (FTRE) quarterly Goodwill came in at $950.3 million in Q2 2026, down 1.54% YoY from $965.2 million in Q2 2025, and little changed on a QoQ basis from $950.8 million in Q1 2026.
Fortrea Holdings (FTRE) Goodwill (2022 - 2026) Analysis & Trends
Fortrea Holdings (FTRE) has 5 years of Goodwill data on file, last reported at $950.3 million in Q2 2026.
- Quarterly Goodwill fell 1.54% year-over-year to $950.3 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $950.3 million (down 1.54% YoY) and the FY2025 annual result came in at $960.0 million, down 43.87% from the prior year.
- Goodwill was little changed at $950.3 million in Q2 2026, from $950.8 million in the prior quarter.
- In the past five years, Goodwill ranged from a high of $2.0 billion in Q2 2022 to a low of $950.3 million in Q2 2026.
- A 5-year average of $1.5 billion and a median of $1.7 billion in 2023 frame the typical range for Goodwill.
- Annual changes were most pronounced in 2023 — Goodwill grew 2.97% — and 2025, when it slumped 45.78%.
- Tracing FTRE's Goodwill over 5 years: stood at $1.7 billion in 2022, then increased by 1.87% to $1.7 billion in 2023, then retreated by 1.67% to $1.7 billion in 2024, then plunged by 43.87% to $960.0 million in 2025, then fell by 1.01% to $950.3 million in 2026.
- The last three Goodwill figures came in at $950.3 million (Q2 2026), $950.8 million (Q1 2026), and $960.0 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Fortrea Holdings | 1.66 Bn | 1.49 Bn | 139.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 950.30 Mn |
| Mar 31, 2026 | 950.80 Mn |
| Dec 31, 2025 | 960.00 Mn |
| Sep 30, 2025 | 958.10 Mn |
| Jun 30, 2025 | 965.20 Mn |
| Mar 31, 2025 | 1.24 Bn |
| Dec 31, 2024 | 1.71 Bn |
| Sep 30, 2024 | 1.77 Bn |
| Jun 30, 2024 | 1.73 Bn |
| Mar 31, 2024 | 1.73 Bn |
| Dec 31, 2023 | 1.74 Bn |
| Sep 30, 2023 | 1.99 Bn |
| Jun 30, 2023 | 1.74 Bn |
| Mar 31, 2023 | 1.72 Bn |
| Dec 31, 2022 | 1.71 Bn |
| Sep 30, 2022 | 1.94 Bn |
| Jun 30, 2022 | 2.00 Bn |